School of Medicine and Health Sciences Poster Presentations

Title

Hypertriglyceridemia Among Transgender Patients on Hormone Therapy

Poster Number

255

Document Type

Poster

Status

Medical Student

Abstract Category

Health Sciences

Keywords

hypertriglyceridemia, transgender medicine, hormone replacement therapy

Publication Date

Spring 2018

Abstract

The field of transgender medicine is growing but research is needed in many areas such as the long term effects of hormone therapy. This study sought to determine 1) hypertriglyceridemia prevalence in patients both before and during hormone therapy; 2) whether or not hypertriglyceridemia is related to dose and/or formulation of estrogen or testosterone; 3) whether hypertriglyceridemia was related to other factors such as medications, BMI, blood pressure, and race/ethnicity. This retrospective study collected data from patients at the MFA endocrinology clinic and from Whitman Walker Clinic. Specifically, it included approximately 500 subjects, both trans men and trans women, on various types of estrogen or testosterone therapy. The data has been collected but has not been analyzed. Although no conclusions can be drawn at this time, the results from this study will hopefully inform clinicians and patients regarding potential adverse effects of hormone therapy.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Open Access

1

This document is currently not available here.

Share

COinS
 

Hypertriglyceridemia Among Transgender Patients on Hormone Therapy

The field of transgender medicine is growing but research is needed in many areas such as the long term effects of hormone therapy. This study sought to determine 1) hypertriglyceridemia prevalence in patients both before and during hormone therapy; 2) whether or not hypertriglyceridemia is related to dose and/or formulation of estrogen or testosterone; 3) whether hypertriglyceridemia was related to other factors such as medications, BMI, blood pressure, and race/ethnicity. This retrospective study collected data from patients at the MFA endocrinology clinic and from Whitman Walker Clinic. Specifically, it included approximately 500 subjects, both trans men and trans women, on various types of estrogen or testosterone therapy. The data has been collected but has not been analyzed. Although no conclusions can be drawn at this time, the results from this study will hopefully inform clinicians and patients regarding potential adverse effects of hormone therapy.